Quick Takeaways
- Jennifer K. Simpson has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Jennifer K. Simpson
- Location
- New York, NY
- Signature
- /s/ Joshua L. Colburn, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jennifer K. Simpson and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: EAGLE PHARMACEUTICALS, INC. ().
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jennifer K. Simpson
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| EGRX | EAGLE PHARMACEUTICALS, INC. | Director | 07 Mar 2023 | |||
| LADX | LadRx Corp | Director | 15 Jan 2024 | |||
| PBLA | Panbela Therapeutics, Inc. | President and CEO, Director | 01 Oct 2024 |
Insider Transactions Reported by Jennifer K. Simpson:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.